46 research outputs found

    Charlene J. Sato's "Ethnic Styles in Classroom Discourse"

    Get PDF
    The loss ofa leading figure, Charlene Sato, has lead to a variety of projects to commemorate her life. This synopsis looks at one ofher many publications, a study carried out in 1982, which dealt with interethnic communication styles and its relationship to participation in the ESL classroom. The present paper will first summarize her study and then address some ofthe issues Sato introduces in the article

    Expressive and Instrumental Offending: Reconciling the Paradox of Specialisation and Versatility

    Get PDF
    Although previous research into specialisation has been dominated by the debate over the existence of specialisation versus versatility, it is suggested that research needs to move beyond the restrictions of this dispute. The current study explores the criminal careers of 200 offenders based on their criminal records, obtained from a police database in the North West of England, aiming to understand the patterns and nature of specialisation by determining the presence of differentiation within their general offending behaviours and examining whether the framework of Expressive and Instrumental offending styles can account for any specialised tendencies that emerge. Fifty-eight offences were subjected to Smallest Space Analysis. Results revealed that a model of criminal differentiation could be identified and that any specialisation is represented in terms of Expressive and Instrumental offending styles

    Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor

    Get PDF
    The blood-brain barrier (BBB) is a critical structure that serves as the gatekeeper between the central nervous system and the rest of the body. It is the responsibility of the BBB to facilitate the entry of required nutrients into the brain and to exclude potentially harmful compounds; however, this complex structure has remained difficult to model faithfully in vitro. Accurate in vitro models are necessary for understanding how the BBB forms and functions, as well as for evaluating drug and toxin penetration across the barrier. Many previous models have failed to support all the cell types involved in the BBB formation and/or lacked the flow-created shear forces needed for mature tight junction formation. To address these issues and to help establish a more faithful in vitro model of the BBB, we have designed and fabricated a microfluidic device that is comprised of both a vascular chamber and a brain chamber separated by a porous membrane. This design allows for cell-to-cell communication between endothelial cells, astrocytes, and pericytes and independent perfusion of both compartments separated by the membrane. This NeuroVascular Unit (NVU) represents approximately one-millionth of the human brain, and hence, has sufficient cell mass to support a breadth of analytical measurements. The NVU has been validated with both fluorescein isothiocyanate (FITC)-dextran diffusion and transendothelial electrical resistance. The NVU has enabled in vitro modeling of the BBB using all human cell types and sampling effluent from both sides of the barrier

    Monitoring Alaskan Arctic shelf ecosystems through collaborative observation networks

    Get PDF
    © The Author(s), 2022. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Danielson, S. L., Grebmeier, J. M., Iken, K., Berchok, C., Britt, L., Dunton, K. H., Eisner, L., V. Farley, E., Fujiwara, A., Hauser, D. D. W., Itoh, M., Kikuchi, T., Kotwicki, S., Kuletz, K. J., Mordy, C. W., Nishino, S., Peralta-Ferriz, C., Pickart, R. S., Stabeno, P. S., Stafford. K. M., Whiting, A. V., & Woodgate, R. Monitoring Alaskan Arctic shelf ecosystems through collaborative observation networks. Oceanography, 35(2), (2022): 52, https://doi.org/10.5670/oceanog.2022.119.Ongoing scientific programs that monitor marine environmental and ecological systems and changes comprise an informal but collaborative, information-rich, and spatially extensive network for the Alaskan Arctic continental shelves. Such programs reflect contributions and priorities of regional, national, and international funding agencies, as well as private donors and communities. These science programs are operated by a variety of local, regional, state, and national agencies, and academic, Tribal, for-profit, and nongovernmental nonprofit entities. Efforts include research ship and autonomous vehicle surveys, year-long mooring deployments, and observations from coastal communities. Inter-program coordination allows cost-effective leveraging of field logistics and collected data into value-added information that fosters new insights unattainable by any single program operating alone. Coordination occurs at many levels, from discussions at marine mammal co-management meetings and interagency meetings to scientific symposia and data workshops. Together, the efforts represented by this collection of loosely linked long-term monitoring programs enable a biologically focused scientific foundation for understanding ecosystem responses to warming water temperatures and declining Arctic sea ice. Here, we introduce a variety of currently active monitoring efforts in the Alaskan Arctic marine realm that exemplify the above attributes.Funding sources include the following: ALTIMA: BOEM M09PG00016, M12PG00021, and M13PG00026; AMBON: NOPP-NA14NOS0120158 and NOPP-NA19NOS0120198; Bering Strait moorings: NSF-OPP-AON-PLR-1758565, NSF-OPP-PLR-1107106; BLE-LTER: NSF-OPP-1656026; CEO: NPRB-L36, ONR N000141712274 and N000142012413; DBO: NSF-AON-1917469 and NOAA-ARP CINAR-22309.07; HFR, AOOS Arctic glider, and Passive Acoustics at CEO and Bering Strait: NA16NOS0120027; WABC: NSF-OPP-1733564. JAMSTEC: partial support by ArCS Project JPMXD1300000000 and ArCS II Project JPMXD1420318865; Seabird surveys: BOEM M17PG00017, M17PG00039, and M10PG00050, and NPRB grants 637, B64, and B67. This publication was partially funded by the Cooperative Institute for Climate, Ocean, & Ecosystem Studies (CICOES) under NOAA Cooperative Agreement NA20OAR4320271, and represents contribution 2021-1163 to CICOES, EcoFOCI-1026, and 5315 to PMEL. This is NPRB publication ArcticIERP-43

    Breast tumor copy number aberration phenotypes and genomic instability

    Get PDF
    BACKGROUND: Genomic DNA copy number aberrations are frequent in solid tumors, although the underlying causes of chromosomal instability in tumors remain obscure. Genes likely to have genomic instability phenotypes when mutated (e.g. those involved in mitosis, replication, repair, and telomeres) are rarely mutated in chromosomally unstable sporadic tumors, even though such mutations are associated with some heritable cancer prone syndromes. METHODS: We applied array comparative genomic hybridization (CGH) to the analysis of breast tumors. The variation in the levels of genomic instability amongst tumors prompted us to investigate whether alterations in processes/genes involved in maintenance and/or manipulation of the genome were associated with particular types of genomic instability. RESULTS: We discriminated three breast tumor subtypes based on genomic DNA copy number alterations. The subtypes varied with respect to level of genomic instability. We find that shorter telomeres and altered telomere related gene expression are associated with amplification, implicating telomere attrition as a promoter of this type of aberration in breast cancer. On the other hand, the numbers of chromosomal alterations, particularly low level changes, are associated with altered expression of genes in other functional classes (mitosis, cell cycle, DNA replication and repair). Further, although loss of function instability phenotypes have been demonstrated for many of the genes in model systems, we observed enhanced expression of most genes in tumors, indicating that over expression, rather than deficiency underlies instability. CONCLUSION: Many of the genes associated with higher frequency of copy number aberrations are direct targets of E2F, supporting the hypothesis that deregulation of the Rb pathway is a major contributor to chromosomal instability in breast tumors. These observations are consistent with failure to find mutations in sporadic tumors in genes that have roles in maintenance or manipulation of the genome

    Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

    Get PDF
    Introduction: The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. We aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures. Methods: In a prospective, UK-wide, multicentre MRI follow-up study (C-MORE), adults (aged ≥18 years) discharged from hospital following COVID-19 who were included in Tier 2 of the Post-hospitalisation COVID-19 study (PHOSP-COVID) and contemporary controls with no evidence of previous COVID-19 (SARS-CoV-2 nucleocapsid antibody negative) underwent multiorgan MRI (lungs, heart, brain, liver, and kidneys) with quantitative and qualitative assessment of images and clinical adjudication when relevant. Individuals with end-stage renal failure or contraindications to MRI were excluded. Participants also underwent detailed recording of symptoms, and physiological and biochemical tests. The primary outcome was the excess burden of multiorgan abnormalities (two or more organs) relative to controls, with further adjustments for potential confounders. The C-MORE study is ongoing and is registered with ClinicalTrials.gov, NCT04510025. Findings: Of 2710 participants in Tier 2 of PHOSP-COVID, 531 were recruited across 13 UK-wide C-MORE sites. After exclusions, 259 C-MORE patients (mean age 57 years [SD 12]; 158 [61%] male and 101 [39%] female) who were discharged from hospital with PCR-confirmed or clinically diagnosed COVID-19 between March 1, 2020, and Nov 1, 2021, and 52 non-COVID-19 controls from the community (mean age 49 years [SD 14]; 30 [58%] male and 22 [42%] female) were included in the analysis. Patients were assessed at a median of 5·0 months (IQR 4·2–6·3) after hospital discharge. Compared with non-COVID-19 controls, patients were older, living with more obesity, and had more comorbidities. Multiorgan abnormalities on MRI were more frequent in patients than in controls (157 [61%] of 259 vs 14 [27%] of 52; p<0·0001) and independently associated with COVID-19 status (odds ratio [OR] 2·9 [95% CI 1·5–5·8]; padjusted=0·0023) after adjusting for relevant confounders. Compared with controls, patients were more likely to have MRI evidence of lung abnormalities (p=0·0001; parenchymal abnormalities), brain abnormalities (p<0·0001; more white matter hyperintensities and regional brain volume reduction), and kidney abnormalities (p=0·014; lower medullary T1 and loss of corticomedullary differentiation), whereas cardiac and liver MRI abnormalities were similar between patients and controls. Patients with multiorgan abnormalities were older (difference in mean age 7 years [95% CI 4–10]; mean age of 59·8 years [SD 11·7] with multiorgan abnormalities vs mean age of 52·8 years [11·9] without multiorgan abnormalities; p<0·0001), more likely to have three or more comorbidities (OR 2·47 [1·32–4·82]; padjusted=0·0059), and more likely to have a more severe acute infection (acute CRP >5mg/L, OR 3·55 [1·23–11·88]; padjusted=0·025) than those without multiorgan abnormalities. Presence of lung MRI abnormalities was associated with a two-fold higher risk of chest tightness, and multiorgan MRI abnormalities were associated with severe and very severe persistent physical and mental health impairment (PHOSP-COVID symptom clusters) after hospitalisation. Interpretation: After hospitalisation for COVID-19, people are at risk of multiorgan abnormalities in the medium term. Our findings emphasise the need for proactive multidisciplinary care pathways, with the potential for imaging to guide surveillance frequency and therapeutic stratification
    corecore